ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Development of Biosimilars"
Episode Synopsis
Join us for the second episode of the GHAPP & RhAPP Biosimilar Podcast Series, where host Amanda Mixon, PA-C, sits down with Tanya Golovanoff, PharmD, to explore the intricate world of biosimilar development. As biosimilars continue to reshape the treatment landscape in rheumatology and gastroenterology, understanding their development process is essential for healthcare providers navigating this evolving field.This episode takes a deep dive into the scientific and regulatory journey behind biosimilars, breaking down the extensive research, rigorous clinical testing, and advanced manufacturing techniques that ensure these therapies match the safety and efficacy of their reference biologics. The discussion sheds light on the analytical testing required to establish biosimilarity, the importance of immunogenicity assessments, and the real-world implications of biosimilars in clinical practice. With rheumatology and gastroenterology providers at the forefront of patient education, the conversation also highlights the importance of understanding biosimilar naming conventions, explaining the rationale behind the structured FDA suffix system and how it impacts prescribing.Biosimilars offer a promising avenue for increasing patient access to biologic therapies while reducing healthcare costs. However, ensuring a smooth transition for patients requires APPs to stay informed and confident in explaining the role of biosimilars in treatment plans. As insurance mandates shift prescribing patterns, the need for clarity around biosimilars has never been more critical. Tanya Golovanoff’s expertise provides a clear and compelling perspective on how biosimilars are developed, manufactured, and named, offering valuable insights for healthcare providers managing treatment decisions in gastroenterology, rheumatology, and immunology.Tune in to this engaging discussion and stay ahead of the latest advancements in biosimilars. Subscribe to GHAPP & RhAPPcast on your favorite podcast platform and explore expert-driven resources on the RhAPP ACE App to enhance your clinical knowledge and support optimal patient care.Please take our evaluation regarding this podcast here: https://www.rhapp.org/bio-podcast-eval
In God we trust